Table 2.
Site | Crude incidence rates per 100,000 | Age-standardized incidence rates per 100,000a) | ||||
---|---|---|---|---|---|---|
|
|
|||||
Both sexes | Men | Women | Both sexes | Men | Women | |
All sites | 531.6 | 561.2 | 502.1 | 276.7 | 289.9 | 276.1 |
| ||||||
Lip, oral cavity, and pharynx | 8.2 | 11.8 | 4.6 | 4.3 | 6.3 | 2.5 |
| ||||||
Esophagus | 5.3 | 9.4 | 1.2 | 2.4 | 4.4 | 0.6 |
| ||||||
Stomach | 51.2 | 68.3 | 34.1 | 24.0 | 34.0 | 15.3 |
| ||||||
Colon and rectum | 56.5 | 66.8 | 46.3 | 26.4 | 33.8 | 19.8 |
| ||||||
Liverb) | 28.1 | 41.9 | 14.3 | 12.9 | 20.9 | 5.7 |
| ||||||
Gallbladderc) | 16.6 | 17.9 | 15.3 | 6.6 | 8.3 | 5.3 |
| ||||||
Pancreas | 17.9 | 18.5 | 17.3 | 7.7 | 8.9 | 6.7 |
| ||||||
Larynx | 2.1 | 3.9 | 0.2 | 0.9 | 1.8 | 0.1 |
| ||||||
Lungd) | 64.5 | 84.8 | 44.3 | 27.6 | 39.4 | 18.6 |
| ||||||
Breast | 54.5 | 0.4 | 108.3 | 33.1 | 0.2 | 66.1 |
| ||||||
Cervix uteri | 5.8 | - | 11.5 | 3.7 | - | 7.4 |
| ||||||
Corpus uteri | 7.1 | - | 14.1 | 4.2 | - | 8.3 |
| ||||||
Ovary | 6.1 | - | 12.3 | 3.7 | - | 7.4 |
| ||||||
Prostate | 43.4 | 87.0 | - | 18.4 | 40.3 | - |
| ||||||
Testis | 0.7 | 1.3 | - | 0.7 | 1.3 | - |
| ||||||
Kidney | 13.5 | 18.9 | 8.0 | 7.4 | 10.8 | 4.2 |
| ||||||
Bladder | 9.9 | 16.3 | 3.6 | 4.1 | 7.6 | 1.3 |
| ||||||
Brain and CNS | 4.2 | 4.6 | 3.9 | 3.0 | 3.4 | 2.7 |
| ||||||
Thyroid | 65.6 | 34.8 | 96.3 | 47.6 | 24.8 | 71.2 |
| ||||||
Hodgkin lymphoma | 0.7 | 0.8 | 0.5 | 0.6 | 0.7 | 0.5 |
| ||||||
Non-Hodgkin lymphoma | 11.7 | 13.5 | 9.9 | 6.7 | 8.3 | 5.4 |
| ||||||
Multiple myeloma | 4.1 | 4.3 | 3.9 | 1.8 | 2.1 | 1.6 |
| ||||||
Leukemia | 7.7 | 8.9 | 6.5 | 5.7 | 6.7 | 4.6 |
| ||||||
Other and ill defined | 46.5 | 47.2 | 45.9 | 23.2 | 25.9 | 20.9 |
CNS, central nervous system.
ge adjusted to the world standard population,
Includes the liver and intrahepatic bile duct,
Includes the gallbladder and other/unspecified parts of the biliary tract,
Includes the lung and bronchus.